We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Enterprise Products Partners
EPD
$83.6B
| $6.01M | 0.01% |
175,903
+9,853
| +6% | +$328K |
|
427
FerroAtlántica
GSM
$628M
| $5.74M | 0.01% |
1,548,152
+1,333,772
| +622% | +$5.14M |
|
428
DXP Enterprises
DXPE
$2.49B
| $5.64M | 0.01% |
68,537
-2,386
| -3% | -$220K |
|
429
IBEX
IBEX
$480M
| $5.57M | 0.01% |
228,908
-8,005
| -3% | -$192K |
|
430
NatWest
NWG
$70.6B
| $5.42M | 0.01% |
453,078
+87,852
| +24% | +$985K |
|
431
EverQuote
EVER
$960M
| $5.4M | 0.01% |
206,284
+22,776
| +12% | +$522K |
|
432
CRA International
CRAI
$1.16B
| $5.35M | 0.01% |
30,892
-1,013
| -3% | -$188K |
|
433
Newmont
NEM
$96.4B
| $5.35M | 0.01% |
+110,794
| New | +$4.86M |
|
434
Berkshire Hathaway Class B
BRK.B
$1.11T
| $5.33M | 0.01% |
10,010
-4,955
| -33% | -$2.41M |
|
435
Broadcom
AVGO
$1.81T
| $5.27M | 0.01% |
31,468
-4,923
| -14% | -$1.04M |
|
436
Stewart Information Services
STC
$2.12B
| $5.18M | 0.01% |
72,592
-2,372
| -3% | -$161K |
|
437
Walmart Inc
WMT
$900B
| $5.17M | 0.01% |
58,872
-20,970
| -26% | -$1.97M |
|
438
Ecovyst
ECVT
$1.35B
| $4.77M | 0.01% |
769,908
-1,631,903
| -68% | -$12.1M |
|
439
iShares Russell 2000 Value ETF
IWN
$14.5B
| $4.68M | 0.01% |
30,976
-24,364
| -44% | -$3.94M |
|
440
Arcosa
ACA
$7.13B
| $4.67M | 0.01% |
60,532
-109,855
| -64% | -$10.1M |
|
441
Novartis
NVS
$304B
| $4.62M | 0.01% |
41,483
-11,876
| -22% | -$1.26M |
|
442
Global Indemnity Group
GBLI
$405M
| $4.51M | 0.01% |
130,833
+26,886
| +26% | +$952K |
|
443
Oppenheimer Holdings
OPY
$1.2B
| $4.27M | 0.01% |
71,568
+58,735
| +458% | +$3.8M |
|
|
CTO
444
CTO Realty Growth
CTO
$740M
| $4.22M | 0.01% |
218,436
-2,895
| -1% | -$56.2K |
|
445
ING
ING
$95.1B
| $3.93M | ﹤0.01% |
200,726
+34,325
| +21% | +$610K |
|
446
Huntington Ingalls Industries
HII
$11.8B
| $3.84M | ﹤0.01% |
18,833
-733
| -4% | -$139K |
|
447
Smith & Nephew
SNN
$13.7B
| $3.69M | ﹤0.01% |
129,893
+40,211
| +45% | +$1.07M |
|
448
Ooma
OOMA
$608M
| $3.6M | ﹤0.01% |
274,722
-107,857
| -28% | -$1.53M |
|
449
TJX Companies
TJX
$178B
| $3.6M | ﹤0.01% |
29,516
+888
| +3% | +$108K |
|
450
Amazon
AMZN
$2.48T
| $3.58M | ﹤0.01% |
18,831
-9,417
| -33% | -$2.04M |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.